1. Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure.
- Author
-
Li Y, Takemura G, Kosai K, Takahashi T, Okada H, Miyata S, Yuge K, Nagano S, Esaki M, Khai NC, Goto K, Mikami A, Maruyama R, Minatoguchi S, Fujiwara T, and Fujiwara H
- Subjects
- Adenoviridae genetics, Animals, Caspases analysis, Cicatrix pathology, Coronary Vessels, Defective Viruses genetics, Fas Ligand Protein, Genes, Synthetic, Genetic Therapy, Genetic Vectors therapeutic use, Heart Failure etiology, Heart Failure prevention & control, Humans, Hypertrophy, Left Ventricular etiology, Hypertrophy, Left Ventricular physiopathology, Hypertrophy, Left Ventricular prevention & control, Immunoglobulin G genetics, Ligation, Male, Membrane Glycoproteins deficiency, Membrane Glycoproteins genetics, Mice, Mice, Inbred C57BL, Mice, Mutant Strains, Myocardial Infarction complications, Myocardial Infarction therapy, Solubility, Time Factors, fas Receptor genetics, fas Receptor therapeutic use, Apoptosis physiology, Granulation Tissue pathology, Heart Failure physiopathology, Membrane Glycoproteins physiology, Myocardial Infarction physiopathology, Myocardium pathology, Ventricular Remodeling physiology, fas Receptor physiology
- Abstract
In myocardial infarction (MI), granulation tissue cells disappear via apoptosis to complete a final scarring with scanty cells. Blockade of this apoptosis was reported to improve post-MI ventricular remodeling and heart failure. However, the molecular biological mechanisms for the apoptosis are unknown. Fas and Fas ligand were overexpressed in the granulation tissue at the subacute stage of MI (1 week after MI) in mice, where apoptosis frequently occurred. In mice lacking functioning Fas (lpr strain) and in those lacking Fas ligand (gld strain), apoptotic rate of granulation tissue cells was significantly fewer compared with that of genetically controlled mice, and post-MI ventricular remodeling and dysfunction were greatly attenuated. Mice were transfected with adenovirus encoding soluble Fas (sFas), a competitive inhibitor of Fas ligand, on the third day of MI. The treatment resulted in suppression of granulation tissue cell apoptosis and produced a thick, cell-rich infarct scar containing rich vessels and bundles of smooth muscle cells with a contractile phenotype at the chronic stage (4 weeks after MI). This accompanied not only alleviation of heart failure but also survival improvement. However, the sFas gene delivery during scar tissue phase was ineffective, suggesting that beneficial effects of the sFas gene therapy owes to inhibition of granulation tissue cell apoptosis. The Fas/Fas ligand interaction plays a critical role for granulation tissue cell apoptosis after MI. Blockade of this apoptosis by interfering with the Fas/Fas ligand interaction may become one of the therapeutic strategies against chronic heart failure after large MI.
- Published
- 2004
- Full Text
- View/download PDF